Skip to main navigation Skip to search Skip to main content

Protocol for the selection of Mycobacterium tuberculosis spontaneous resistant mutants to D-cycloserine

Research output: Contribution to scientific journalArticle in an indexed scientific journalpeer-review

Abstract

Mycobacterium tuberculosis (MTB) is known for its adaptive capability in developing resistance to antibiotics, through the selection of spontaneous mutations that arise during treatment. Generating spontaneous antibiotic-resistant mutants in vitro is challenging but necessary for studying this phenomenon. A protocol was designed and tested to select stable, MTB spontaneous, d-cycloserine (DCS) resistant mutants. Twenty-four colonies resistant to DCS were selected, demonstrating an increase between 1 and 4 times the Minimum Inhibitory Concentration (MIC) set for Mycobacterium tuberculosis H37Rv ATCC 27294 reference strain.

Original languageEnglish
Article number102690
JournalMethodsX
Volume12
DOIs
StatePublished - Jun 2024

Bibliographical note

Publisher Copyright:
© 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antibiotics
  • Drug-resistant
  • H37Rv
  • Mycobacterium tuberculosis
  • Spontaneous mutants

Types Minciencias

  • Artículos de investigación con calidad A2 / Q2

Fingerprint

Dive into the research topics of 'Protocol for the selection of Mycobacterium tuberculosis spontaneous resistant mutants to D-cycloserine'. Together they form a unique fingerprint.

Cite this